Thrombocytopenia and platelet transfusions in ICU patients: An international inception cohort study (PLOT-ICU) Journal Article


Authors: Anthon, C. T.; Pène, F.; Perner, A.; Azoulay, E.; Puxty, K.; Van De Louw, A.; Barratt-Due, A.; Chawla, S.; Castro, P.; Póvoa, P.; Coelho, L.; Metaxa, V.; Kochanek, M.; Liebregts, T.; Kander, T.; Hästbacka, J.; Andreasen, J. B.; Péju, E.; Nielsen, L. B.; Hvas, C. L.; Dufranc, E.; Canet, E.; Lundqvist, L.; Wright, C. J.; Schmidt, J.; Uhel, F.; Ait-Oufella, H.; Krag, M.; Cos Badia, E.; Díaz-Lagares, C.; Menat, S.; Voiriot, G.; Clausen, N. E.; Lorentzen, K.; Kvåle, R.; Hildebrandt, T.; Holten, A. R.; Strand, K.; Tzalavras, A.; Bestle, M. H.; Klepstad, P.; Fernandez, S.; Vimpere, D.; Paulino, C.; Graça, C.; Lueck, C.; Juhl, C. S.; Costa, C.; Bådstøløkken, P. M.; Miranda, T.; Lêdo, L. S. A.; Sousa Torres, J. C.; Granholm, A.; Møller, M. H.; Russell, L.; on behalf of the PLOT-ICU Collaborators and the Nine-I Study Group
Contributors: Remor, N.; Carr, S.; Yang, G.
Article Title: Thrombocytopenia and platelet transfusions in ICU patients: An international inception cohort study (PLOT-ICU)
Abstract: Purpose: Thrombocytopenia (platelet count < 150 × 109/L) is common in intensive care unit (ICU) patients and is likely associated with worse outcomes. In this study we present international contemporary data on thrombocytopenia in ICU patients. Methods: We conducted a prospective cohort study in adult ICU patients in 52 ICUs across 10 countries. We assessed frequencies of thrombocytopenia, use of platelet transfusions and clinical outcomes including mortality. We evaluated pre-selected potential risk factors for the development of thrombocytopenia during ICU stay and associations between thrombocytopenia at ICU admission and 90-day mortality using pre-specified logistic regression analyses. Results: We analysed 1166 ICU patients; the median age was 63 years and 39.5% were female. Overall, 43.2% (95% confidence interval (CI) 40.4–46.1) had thrombocytopenia; 23.4% (20–26) had thrombocytopenia at ICU admission, and 19.8% (17.6–22.2) developed thrombocytopenia during their ICU stay. Absence of acquired immune deficiency syndrome (AIDS), non-cancer-related immune deficiency, liver failure, male sex, septic shock, and bleeding at ICU admission were associated with the development of thrombocytopenia during ICU stay. Among patients with thrombocytopenia, 22.6% received platelet transfusion(s), and 64.3% of in-ICU transfusions were prophylactic. Patients with thrombocytopenia had higher occurrences of bleeding and death, fewer days alive without the use of life-support, and fewer days alive and out of hospital. Thrombocytopenia at ICU admission was associated with 90-day mortality (adjusted odds ratio 1.7; 95% CI 1.19–2.42). Conclusion: Thrombocytopenia occurred in 43% of critically ill patients and was associated with worse outcomes including increased mortality. Platelet transfusions were given to 23% of patients with thrombocytopenia and most were prophylactic. © 2023, The Author(s).
Keywords: adult; controlled study; aged; middle aged; retrospective studies; major clinical study; mortality; chemotherapy; prospective study; prospective studies; cohort studies; bleeding; thrombocytopenia; cohort analysis; hematopoietic stem cell transplantation; retrospective study; risk factor; risk assessment; liver failure; intensive care unit; intensive care units; thrombosis; hospital admission; immune deficiency; antithrombocytic agent; thrombocyte transfusion; hypertensive factor; anticoagulant agent; critical illness; critically ill patient; clinical outcome; septic shock; hemorrhage; platelet transfusion; humans; human; male; female; article; invasive ventilation
Journal Title: Intensive Care Medicine
Volume: 49
Issue: 11
ISSN: 0342-4642
Publisher: Springer Verlag  
Date Published: 2023-11-01
Start Page: 1327
End Page: 1338
Language: English
DOI: 10.1007/s00134-023-07225-2
PUBMED: 37812225
PROVIDER: scopus
PMCID: PMC10622358
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- Erratum published at DOI: 10.1007/s00134-023-07291-6 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sanjay Chawla
    49 Chawla
  2. Natalie Theresa Remor
    39 Remor
  3. Gloria Yang
    16 Yang
  4. Sheila Carr
    2 Carr